DIALYSIS

This study tests a new drug called AP301 to see if it can safely lower high blood phosphate levels in people with kidney failure who are on dialysis. About 264 adults and teens will take either AP301 or a low-dose version for 8 weeks, then all receive AP301 for 24 weeks. The goal…

This study looks at whether a campaign called Choosing Wisely can safely reduce unnecessary tests and treatments in intensive care units (ICUs). About 10,000 adult patients in Swedish ICUs will take part. The goal is to see if this approach lowers costs and improves care without …

This study is a large registry that will collect health information from up to 60,000 people with both heart and kidney disease. The goal is to understand what factors lead to worse outcomes and to improve how doctors predict and manage these conditions. No new treatments or proc…

This study looks at 1000 adults in Latin American ICUs who need dialysis for sudden kidney failure. Researchers want to understand how care differs between countries and what affects patient survival. The goal is to gather data to improve future treatment, not to test a new drug …